Evidence map›Paper›PMID 40841105›Full record

ReviewJACC. CardioOncology2025

Cancer Development in Atherosclerotic Cardiovascular Disease: JACC: CardioOncology Short-Form Primer.

Jessie M Dalman, Kathryn J Moore

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in JACC. CardioOncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessie M DalmanCardiovascular Research Center, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA; University of Michigan Medical School, Ann Arbor, Michigan, USA.
Kathryn J MooreCardiovascular Research Center, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA; Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA. Electronic address: kathryn.moore@nyulangone.org.

Funding

Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin ResistanceP01HL131481 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANN MARIE SCHMIDT · 2017 to 2026
$27.3M
The role of immune-responsive gene 1 and itaconate in atherosclerotic diseaseR01HL172365 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KATHRYN J MOORE · 2024 to 2026
$2.3M
Long noncoding RNA regulation of Atherosclerotic Cardiovascular DiseaseR01HL172335 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KATHRYN J MOORE · 2024 to 2026
$2.2M
NHLBI NIH HHS P01 HL131481NHLBI NIH HHS R01 HL172335NHLBI NIH HHS R01 HL172365
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atherosclerosiscardiovascular diseasecoronary artery diseaseepigeneticsheart failuremyocardial infarctionneoplasmreverse cardio-oncologytumor

Identifiers

PMID40841105
PMCPMC12441613

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.